GROWTH CAPITAL ADVISORY

TripleTree Advises Medix Infusion on its Growth Investment from Echo Health Ventures

January 2023
Medix Infusion, which creates access to infusion therapy for patients in rural, suburban and other underserved markets, has closed a $35 million Series B funding round led by Echo Health Ventures. Additional participants included Pittco Direct Investments II, the direct investing arm of Pittco Management, LLC, and initial investor Noro-Moseley Partners. Medix Infusion simultaneously entered into a debt facility with Live Oak Bank to further support its growth.

Read full press release.
Like most websites we use cookies here, but we don't share your information. By continuing your visit, you accept the use of cookies. Find out more